Giraldi Marco, Rossi Gabriele, Bertazzolo Walter, Negri Stefano, Paltrinieri Saverio, Scarpa Paola
Department of Veterinary Medicine, University of Milan, Milan, Italy.
Veterinary Teaching Hospital, University of Milan, Lodi, Italy.
Vet Clin Pathol. 2018 Sep;47(3):448-457. doi: 10.1111/vcp.12646. Epub 2018 Aug 22.
Proteinuria quantification with the urinary protein-to-creatinine (UPC) ratio is part of the diagnostic process in feline patients suspected of chronic kidney disease (CKD). In affected cats, monitoring and substaging of the UPC according to the International Renal Interest Society (IRIS) guidelines is also necessary for appropriate patient management. No information is available about the possible effects of analytical variability on urinary proteins (UPs) and the UPC ratio in cats.
This study aimed to determine whether imprecision and method-dependent differences due to the two dye-binding methods, pyrogallol red-molybdate (PRM) and Coomassie brilliant blue (CBB), could affect IRIS substaging.
Urine samples were collected from proteinuric and nonproteinuric cats. Intra-assay and inter-assay repeatability were assessed with both the PRM and CBB methods. Urinary supernatants (n = 120) were tested using both methods. Agreement between the methods and concordance with sample classification according to IRIS guidelines were determined.
On average, the PRM method yielded a higher CV (UP 8.4 ± 5.2%; UPC 9.5 ± 4.8%) than the CBB method (UP 5.6 ± 2.6%; UPC 7.2 ± 2.6%), but similar rates of misclassification were found in samples with UPC ratios close to the IRIS cut-off. Although the two methods were correlated, the CBB method tended to yield UPs and UPC ratios that were significantly higher (P < 0.0001) than that of the PRM method. The Passing-Bablok test also found constant and proportional errors between the PRM and CBB methods. Concordance in substaging samples according to IRIS was good (k coefficient = 0.62).
The two methods were precise, but the higher UPC ratios obtained with the CBB methods might affect the interpretation using the IRIS guidelines and clinical decisions.
使用尿蛋白与肌酐(UPC)比值进行蛋白尿定量是疑似患有慢性肾病(CKD)的猫科动物诊断过程的一部分。对于患病猫,根据国际肾脏利益协会(IRIS)指南对UPC进行监测和分期对于适当的患者管理也很有必要。目前尚无关于分析变异性对猫尿蛋白(UPs)和UPC比值可能产生的影响的信息。
本研究旨在确定由于两种染料结合法,即邻苯三酚红 - 钼酸盐(PRM)法和考马斯亮蓝(CBB)法导致的不精密度和方法依赖性差异是否会影响IRIS分期。
从蛋白尿和非蛋白尿猫中收集尿液样本。使用PRM和CBB方法评估批内和批间重复性。使用两种方法对120份尿液上清液进行检测。确定两种方法之间的一致性以及与根据IRIS指南的样本分类的一致性。
平均而言,PRM法的变异系数(CV)(UP为8.4±5.2%;UPC为9.5±4.8%)高于CBB法(UP为5.6±2.6%;UPC为7.2±2.6%),但在UPC比值接近IRIS临界值的样本中发现了相似的错误分类率。虽然两种方法具有相关性,但CBB法得出的UPs和UPC比值往往比PRM法显著更高(P<0.0001)。Passing-Bablok检验还发现PRM和CBB方法之间存在恒定和比例误差。根据IRIS对样本分期的一致性良好(k系数 = 0.62)。
两种方法都很精确,但CBB法获得的较高UPC比值可能会影响使用IRIS指南的解释和临床决策。